Moonlake Immunotherapeutics
MLTX
Revenue
0.00
0.000.00%
-Assets
424.43M
▲10.10M▲2.44%
3 Months ChangeLiabilities
119.95M
▼-3.19M▼-2.59%
3 Months ChangeFree Cash Flow
-38.18M
▼-23.02M▼-151.81%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-23
Form 8-K
ID: 0001213900-26-018967
2026-01-08
Form 8-K
ID: 0001213900-26-002344
2025-11-05
Form 8-K
ID: 0001213900-25-106723
2025-11-05
Form 10-Q
ID: 0001821586-25-000022
2025-11-05
Form 8-K
ID: 0001821586-25-000021
2025-09-29
Form 8-K
ID: 0001213900-25-092614
2025-08-05
Form 10-Q
ID: 0001821586-25-000018
2025-08-05
Form 8-K
ID: 0001821586-25-000016
2025-06-06
Form 8-K
ID: 0001213900-25-052140
2025-05-12
Form 10-Q
ID: 0001821586-25-000011